Shionogi & Coの従業員
Shionogi & Coの従業員は何ですか。
Shionogi & Co., Ltd.の従業員は5,485です。
従業員の定義は何ですか。
従業員は、従業員がやっている仕事の種類や自分が働いている仕事の種類に応じて、1時間ごとの賃金の形でもピザワークや年間給与の形でもよい支払いの代償として働きます。
Employment is a relationship between two parties, usually based on a contract where work is paid for, where one party, which may be a corporation, for profit, not-for-profit organization, co-operative or other entity is the employer and the other is the employee.
Employees in some fields or sectors may receive gratuities, bonus payment or stock options. In some types of employment, employees may receive benefits in addition to payment. Benefits can include health insurance, housing, disability insurance or use of a gym. Employment is typically governed by employment laws or regulations or legal contracts.
OTCのセクタHealth Careにおける従業員の企業と比べるShionogi & Co
Shionogi & Coは何をしますか。
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN14770 for Fragile X syndrome and Alzheimer's disease; and S-237648 and S-309309 for Obesity. In addition, the company develops ADR-001 for Decompensated liver cirrhosis; S-723595 for NASH; S-588410 for Esophageal and Bladder cancer; S-488210 for Head and neck squamouscell carcinoma; S-588210 for Solid tumor; S-222611 for Malignant tumor; S-770108 for Idiopathic pulmonary fibrosis; SR-0379 for Cutaneous ulcer; S-005151 for Stroke and Epidermolysis bullosa; S-531011 for Solid tumor; S-0373 for Spinocerebellar ataxia; and S-600918 and S-217622 for COVID-19, as well as S-555739 for Control of the aggravation of COVID-19. Further, it offers antibody test kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to develop antimalarial drugs. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Shionogi & Coと類似の従業員
- Embryの従業員は5,436です。
- GoHealthの従業員は5,448です。
- AMKOR Technologyの従業員は5,450です。
- AF Gruppen ASAの従業員は5,471です。
- Squareの従業員は5,477です。
- Veeva Systems A Dl ,00001の従業員は5,482です。
- Shionogi & Coの従業員は5,485です。
- Reliance Infrastructureの従業員は5,493です。
- Pool Dl ,001の従業員は5,500です。
- Austalの従業員は5,500です。
- Indoco Remediesの従業員は5,500です。
- Beximco Pharmaceuticalsの従業員は5,500です。
- Comba Telecom Systemsの従業員は5,500です。